Pricing and Reimbursement in U.S. Pharmaceutical Markets
---- Acknowledgements -----
Revised version to appear in Patricia M. Danzon and Sean Nicholson, eds., The Economics of the Biopharmaceutical Industry. The authors have benefited from discussions with Richard G. Frank and E. Mick Kolassa, but are solely responsible for the views expressed herein. This research was not sponsored. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.